ORIFARM GROUP A/S: Financial statements 2024
CVR: 27347282
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2024. In 2024, the company reported revenue of EUR 3,791,000 and a net result of EUR 3,260,000 compared with EUR 22,442,000 the year before. That is an increase of 3.5% compared with the year before. The profit margin was 86%. Equity in the 2024 report amounted to EUR 374,171,000. The solvency ratio was 35.3%. The company had 202 employees in the financial year.
- Revenue
- EUR 3,791,000
- Gross Profit
- EUR 1,995,000
- Profit/Loss
- EUR 3,260,000
- Equity
- EUR 374,171,000
- Total Assets
- EUR 1,059,474,000
- Employees
- 202
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 3.8M EUR | 2M EUR | 3.3M EUR | 374.2M EUR | 202 |
| 2023 | 3.7M EUR | 12.8M EUR | 22.4M EUR | 208.1M EUR | 2244 |
| 2022 | 3.4M EUR | 11.7M EUR | 27.4M EUR | 188.9M EUR | 2136 |
| 2021 | 1.4M EUR | -3.6M EUR | 28.7M EUR | 169.5M EUR | 1955 |
| 2020 | 8.6M EUR | 8.7M EUR | 25.5M EUR | 149M EUR | 1177 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of October 1, 2024, Mads Fink Eriksen is registered as director of ORIFARM GROUP A/S.
As of October 1, 2024, Jacob Lucassen has stepped down as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2023. Revenue came to DKK 3,664,000, and the net result was DKK 22,442,000.
As of April 23, 2024, Stine Schmidt Magnussen has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Lotte Stenkjær Fletcher has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Malene Segnitz Brøndum has joined the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Søren Møller Hansen has left the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Jens Christian Greve has left the board of directors of ORIFARM GROUP A/S.
As of April 23, 2024, Mette Bille Rasmussen has left the board of directors of ORIFARM GROUP A/S.
About ORIFARM GROUP A/S
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.